Abound Wealth Management Novartis Ag Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Abound Wealth Management holds 23 shares of NVS stock, worth $2,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 19
21.05%
Holding current value
$2,448
Previous $2.02 Million
30.8%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,435Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.3 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$862 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$790 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.95MShares$633 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $229B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...